2 - TI Pharma

Chapter 2 Glucocorticoids: metabolic side effects
75. Lundgren M, Buren j, Ruge T, Myrnas T, Eriksson jW. Glucocorticoids down-regulate glucose uptake
46
capacity and insulin-signaling proteins in omental but not subcutaneous human adipocytes. j Clin
Endocrinol Metab. 2004;89(6):2989-97.
76. Turnbow MA, Keller SR, Rice KM, Garner CW. Dexamethasone down-regulation of insulin receptor
substrate-1 in 3T3-L1 adipocytes. j Biol Chem 1994;269(4):2516-20.
77. Sakoda H, Ogihara T, Anai M, Funaki M, Inukai K, Katagiri H, Fukushima Y, Onishi Y, Ono H, Fujishiro M,
Kikushi M, Oka Y, Asano T. Dexamethasone-induced insulin resistance in 3T3-L1 adipocytes is due to
inhibition of glucose transport rather than insulin signal transduction. Diabetes. 2000;49(10):1700-
8.
78. Fasshauer M, Paschke R. Regulation of adipocytokines and insulin resistance. Diabetologia.
2003;46(12):1594-603.
79. Patel jV, Cummings DE, Girod jP, Mascarenhas AV, Hughes EA, Gupta M, Zavanone M, Beck-Peccoz P,
Spada A. Role of metabolically active hormones in the insulin resistance associated with short-term
glucocorticoid treatment. j Negat Results Biomed. 2006;11(5):14.
80. Lewandowski KC, Szosland K, Lewinski A. Short-term dexamethasone administration does not alter
serum adiponectin or resistin concentrations in overweight and obese subjects despite an increase
in insulin resistance. Clin Endocrinol (Oxf). 2006;65(4):551-2.
81. Libe R, Morpurgo PS, Cappiello V, Maffini A, Bondioni S, Locatelli M et al. Ghrelin and adiponectin in
patients with Cushing’s disease before and after successful transsphenoidal surgery. Clin Endocrinol
(Oxf). 2005;62(1):30-6.
82. Udden j, Bjorntorp P, Arner P, Barkeling B, Meurling L, Rossner S. Effects of glucocorticoids on leptin
levels and eating behaviour in women. j Intern Med. 2003;253(2):225-31.
83. Slavin BG, Ong jM, Kern PA. Hormonal regulation of hormone-sensitive lipase activity and mRNA
levels in isolated rat adipocytes. j Lipid Res. 1994;35(9):1535-41.
84. Divertie GD, jensen MD, Miles jM. Stimulation of lipolysis in humans by physiological
hypercortisolemia. Diabetes. 1991;40(10):1228-32.
85. Samra jS, Clark ML, Humphreys SM, MacDonald IA, Bannister PA, Frayn KN. Effects of physiological
hypercortisolemia on the regulation of lipolysis in subcutaneous adipose tissue. j Clin Endocrinol
Metab. 1998;83(2):626-31.
86. Djurhuus CB, Gravholt CH, Nielsen S, Mengel A, Christiansen jS, Schmitz OE, Moller N. Effects of
cortisol on lipolysis and regional interstitial glycerol levels in humans. Am j Physiol Endocrinol
Metab. 2002;283(1):E172-7.
87. Ottosson M, Vikman-Adolfsson K, Enerback S, Olivecrona G, Bjorntorp P. The effects of cortisol
on the regulation of lipoprotein lipase activity in human adipose tissue. j Clin Endocrinol Metab.
1994;79(3):820-5.
88. Arner P, Lithell H, Wahrenberg H, Bronnegard M. Expression of lipoprotein lipase in different human
subcutaneous adipose tissue regions. j Lipid Res. 1991;32(3):423-9.